■ CD8a モノクローナル抗体(品番:65069-1-Ig)

図1. CD8a抗体とCD4抗体を用いた細胞表面マーカー解析
1X10^6 mouse splenocytes were surface stained with APC Anti-Mouse CD4 (APC-65104, Clone: GK1.5), and 0.5 ug Anti-Mouse CD8a (65069-1-Ig, Clone: 53-6.7) and FITC Anti-Rat IgG2a Antibody at dilution 1:200. Cells were not fixed.
図2. アイソタイプコントロール抗体とCD4抗体を用いた細胞表面マーカー解析
1X10^6 mouse splenocytes were surface stained with APC Anti-Mouse CD4 (APC-65104, Clone: GK1.5), and 0.5 ug Rat IgG2a Isotype Control and FITC Anti-Rat IgG2a Antibody at dilution 1:200. Cells were not fixed.
■ CD8a モノクローナル抗体(品番:FITC-65069)

図1. CD8a抗体とCD4抗体を用いた細胞表面マーカー解析
1X10^6 BALB/c mouse splenocytes were surface stained with APC-Anti-Mouse CD4 (APC-65104, Clone: GK1.5) and 0.20 ug FITC-Anti-Mouse CD8a (FITC-65069, Clone: 53-6.7). Cells were not fixed.
図2. アイソタイプコントロール抗体とCD4抗体を用いた細胞表面マーカー解析
1X10^6 BALB/c mouse splenocytes were surface stained with APC-Anti-Mouse CD4 (APC-65104, Clone: GK1.5) and 0.20 ug FITC-Rat IgG2a isotype control antibody. Cells were not fixed.
■ CD8a モノクローナル抗体(品番:PE-65069)

図1. CD8a抗体とアイソタイプコントロール抗体を用いた細胞表面マーカー解析
1X10^6 C57BL/6 mouse splenocytes were surface stained with 0.20 ug PE-Anti-Mouse CD8a (PE-65069, clone 53-6.7) (red) or 0.20 ug PE-rat IgG2a isotype control (blue). Samples were not fixed.
■ CD8a モノクローナル抗体(品番:APC-65069)

図1. CD8a抗体とCD4抗体を用いた細胞表面マーカー解析
1X10^6 BALB/c mouse splenocytes were surface stained with FITC-Anti-Mouse CD4 (FITC-65104, Clone: GK1.5) and 0.20 ug APC-Anti-Mouse CD8a (APC-65069, Clone: 53-6.7). Cells were not fixed.
図2. アイソタイプコントロール抗体とCD4抗体を用いた細胞表面マーカー解析
1X10^6 BALB/c mouse splenocytes were surface stained with FITC-Anti-Mouse CD4 (FITC-65104, Clone: GK1.5) and 0.20 ug APC-Rat IgG2a isotype control antibody. Cells were not fixed.
■ CD8a モノクローナル抗体(品番:CL488-65069)

図1. CD8a抗体とCD4抗体を用いた細胞表面マーカー解析
1X10^6 BALB/c mouse splenocytes were surface stained with APC-Anti-Mouse CD4 (APC-65104, Clone: GK1.5) and 5.00 ul CoraLite®488-conjugated Anti-Mouse CD8a (CL488-65069, Clone: 53-6.7). Cells were not fixed.
図2. アイソタイプコントロール抗体とCD4抗体を用いた細胞表面マーカー解析
1X10^6 BALB/c mouse splenocytes were surface stained with APC-Anti-Mouse CD4 (APC-65104, Clone: GK1.5) and CoraLite®488-conjugated Rat IgG2a isotype control antibody. Cells were not fixed.
■ CD8a モノクローナル抗体(品番:CL594-65069)

図1. CD8a抗体とCD4抗体を用いた細胞表面マーカー解析
1X10^6 mouse splenocytes were surface stained with CoraLite®647-conjugated Anti-Mouse CD4 (CL647-65104, Clone: GK1.5) and 5.00 ul CoraLite®594-conjugated Anti-Mouse CD8a (CL594-65069, Clone: 53-6.7). Cells were not fixed.
図2. アイソタイプコントロール抗体とCD4抗体を用いた細胞表面マーカー解析
1X10^6 mouse splenocytes were surface stained with CoraLite®647-conjugated Anti-Mouse CD4 (CL647-65104, Clone: GK1.5) and CoraLite®594-conjugated Rat IgG2a isotype control antibody. Cells were not fixed.
■ CD8a モノクローナル抗体(品番:CL647-65069)

図1. CD8a抗体とCD4抗体を用いた細胞表面マーカー解析
1X10^6 BALB/c mouse splenocytes were surface stained with FITC-Anti-Mouse CD4 (FITC-65104, Clone: GK1.5) and 5.00 ul CoraLite®647-conjugated Anti-Mouse CD8a (CL647-65069, Clone: 53-6.7). Cells were not fixed.
図2. アイソタイプコントロール抗体とCD4抗体を用いた細胞表面マーカー解析
1X10^6 BALB/c mouse splenocytes were surface stained with FITC-Anti-Mouse CD4 (FITC-65104, Clone: GK1.5) and CoraLite®647-conjugated Rat IgG2a isotype control antibody. Cells were not fixed.